Evaluation of Family-Based Behavioral Treatments for Youth With Anxiety and Obsessive-Compulsive Disorder

Inclusion Criteria:

• The child is between the ages of 7 to 13 years inclusion at enrollment

• The child has clinically significant symptoms of anxiety and/or OCD, as indicated bya score of 12 or higher on the Pediatric Anxiety Rating Scale (PARS).

• The child is appropriate for anxiety-focused treatment (e.g., anxiety is the primaryor co-primary problem as diagnosed using the Mini-International NeuropsychiatricInterview for Children and Adolescents (MINI-KID).

• One parent/guardian is able and willing to participate in assessment and treatment (e.g., has sufficient English fluency, the decisional capacity to participate, andcan commit to treatment duration).

• The participating parent/guardian lives with their child at least 50% of the timeper self-report.

• Both parent and child are able to read and understand English.

• The child has the intellectual and communication skills to engage in CBT, as judgedby an experienced supervising clinician.

• Participants must be in the state of Texas for treatment sessions/assessments.

Exclusion Criteria:

• the child has a diagnosis of child lifetime bipolar disorder, drug or alcoholdependence, psychotic disorder, or conduct disorder.

• the child has severe, current suicidal/homicidal ideation and/or self-injuryrequiring medical intervention (referrals will be made for appropriate clinicalintervention).

• the child is receiving concurrent therapy for anxiety.

• New Treatments: Initiation of an antidepressant within 12 weeks before studyenrollment OR 6 weeks for an antipsychotic, benzodiazepine, or attention deficithyperactivity disorder (ADHD) medication before study enrollment. EstablishedTreatment changes: Any change in established psychotropic medication (e.g.,antidepressants, anxiolytics, antipsychotic) within 4 weeks before study enrollment.Any medications must remain stable during treatment; downward adjustments due toside effects may be acceptable.